![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV TREATMENT AMONG FENTANYL USERS:
TOWARD UNIVERSAL ACROSS TO ANTIVIRAL THERAPY
|
|
|
AASLD 2022 Nov 4-8
Truong D1 , Shawn S1 , Yung R1 , Liu G1 , Conway B 1,2
1 Vancouver Infectious Diseases Centre, Vancouver, Canada 2 Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada
![1117221](../images/111722/111722-5/1117221.gif)
![1117222](../images/111722/111722-5/1117222.gif)
![1117223](../images/111722/111722-5/1117223.gif)
![1117224](../images/111722/111722-5/1117224.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|